BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34377028)

  • 1. Anlotinib Combined with Cranial Radiotherapy for Non-Small Cell Lung Cancer Patients with Brain Metastasis: A Retrospectively, Control Study.
    He Z; Liu J; Ma Y; Jiang H; Cui Z; Wang G; Wu Y; Liu J; Cai X; Qian J; Huang J; Zhang H; Li H
    Cancer Manag Res; 2021; 13():6101-6111. PubMed ID: 34377028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Anlotinib in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Study.
    Zhong Q; Liu Z
    Cancer Manag Res; 2021; 13():4115-4128. PubMed ID: 34045898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy of brain radiotherapy and EGFR-TKIs is more effective than TKIs alone for EGFR-mutant lung adenocarcinoma patients with asymptomatic brain metastasis.
    Chen Y; Wei J; Cai J; Liu A
    BMC Cancer; 2019 Aug; 19(1):793. PubMed ID: 31399067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between WBRT total dose, intracranial tumor control, and overall survival in NSCLC patients with brain metastases - a single-center retrospective analysis.
    Li Z; Shen D; Zhang J; Zhang J; Yang F; Kong D; Kong J; Zhang A
    BMC Cancer; 2019 Nov; 19(1):1104. PubMed ID: 31727054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment.
    Kong C; Yu S; Qian P; Song X; Wen J; Jiang M; Zhu J; Xu J; Zhao L; Guo Z; Wu J; He X; Zhu X
    Front Oncol; 2023; 13():1169333. PubMed ID: 37771446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR-TKI plus brain radiotherapy versus EGFR-TKI alone in the management of EGFR-mutated NSCLC patients with brain metastases.
    Dong K; Liang W; Zhao S; Guo M; He Q; Li C; Song H; He J; Xia X
    Transl Lung Cancer Res; 2019 Jun; 8(3):268-279. PubMed ID: 31367540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing Whole Brain Radiotherapy Treatment and Dose for Patients With Brain Metastases From Small Cell Lung Cancer.
    Li H; Li W; Qi C; Zhou L; Wen F; Qu Y; Yu H
    Front Oncol; 2021; 11():726613. PubMed ID: 34760692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
    Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
    BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic analysis of stereotactic radiosurgery for brain metastases: a single-center retrospective study.
    Hao Y; Tang T; Ren J; Li G
    Radiol Med; 2023 Oct; 128(10):1271-1283. PubMed ID: 37648956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the efficacy of concurrent EGFR-TKI and whole-brain radiotherapy vs EGFR-TKI alone as a first-line therapy for advanced
    He ZY; Li MF; Lin JH; Lin D; Lin RJ
    Cancer Manag Res; 2019; 11():2129-2138. PubMed ID: 30936745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases.
    Jiang T; Su C; Li X; Zhao C; Zhou F; Ren S; Zhou C; Zhang J
    J Thorac Oncol; 2016 Oct; 11(10):1718-28. PubMed ID: 27237825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical research on stereotactic radiosurgery combined with epithermal growth factor tyrosine kinase inhibitors in the treatment of brain metastasis of non-small cell lung cancer.
    Jia F; Cheng X; Zeng H; Miao J; Hou M
    J BUON; 2019; 24(2):578-584. PubMed ID: 31128009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of EGFR-TKIs combined with craniocerebral radiotherapy on the prognosis of
    Deng G; Tan X; Li Y; Zhang Y; Wang Q; Li J; Li Z
    Front Oncol; 2023; 13():1049855. PubMed ID: 36845694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choice of radiotherapy modality for the combined treatment of non-small cell lung cancer with brain metastases: whole-brain radiation therapy with simultaneous integrated boost or stereotactic radiosurgery.
    Dong X; Wang K; Yang H; Li Y; Hou Y; Chang J; Yuan L
    Front Oncol; 2023; 13():1220047. PubMed ID: 37810984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Timing of Whole Brain Radiotherapy on Survival of Patients with EGFR-mutated 
Non-small Cell Lung Cancer and Brain Metastases].
    Liu G; Zhang X; Tian C; Xia G; Liu P; Zhang Q; Li X; Zhang H; Qin N; Wang J; Zhang S
    Zhongguo Fei Ai Za Zhi; 2016 Aug; 19(8):501-7. PubMed ID: 27561798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of brain radiotherapy plus EGFR-TKI for EGFR-mutated non-small cell lung cancer patients who develop brain metastasis.
    Wang W; Song Z; Zhang Y
    Arch Med Sci; 2018 Oct; 14(6):1298-1307. PubMed ID: 30393484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of upfront craniocerebral radiotherapy and epidermal growth factor receptor-tyrosine kinase inhibitors in patients with epidermal growth factor receptor-positive non-small cell lung cancer with brain metastases.
    Zhou J; Zhou Y; Sun Y; Xiao L; Lu H; Yin X; Fan K
    Front Oncol; 2023; 13():1259880. PubMed ID: 38313214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical characteristic and prognostic factors of leptomeningeal metastasis in patients with non-small-cell lung cancer-a retrospective study from one single cancer institute.
    Yan W; Jing W; An N; Tian Y; Guo D; Kong L; Zhu H; Yu J
    Cancer Med; 2019 Jun; 8(6):2769-2776. PubMed ID: 30993909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis.
    Byeon S; Ham JS; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
    Med Oncol; 2016 Aug; 33(8):97. PubMed ID: 27447711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.